US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 55.780
  • -0.500-0.89%
Close Dec 13 16:00 ET
  • 55.700
  • -0.080-0.14%
Post 20:01 ET
113.13BMarket Cap-15.58P/E (TTM)

About Bristol-Myers Squibb Company

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Company Profile

SymbolBMY
Company NameBristol-Myers Squibb
Listing DateJun 1, 1969
Issue Price40.50
Founded1933
CEODr. Christopher S. Boerner, PhD
MarketNYSE
Employees34100
Fiscal Year Ends12-31
AddressRoute 206 & Province Line Road
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08543
Phone1-609-252-4621
Websitehttp://www.bms.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Christopher S. Boerner, PhD
  • Chairman of the Board and Chief Executive Officer
  • 8.46M
  • David V. Elkins
  • Executive Vice President and Chief Financial Officer
  • 7.17M
  • Dr. Samit Hirawat, M.D.
  • Executive Vice President, Chief Medical Officer and Head of Development
  • 6.23M
  • Amanda Ahn Poole
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Adam Lenkowsky
  • Executive Vice President and Chief Commercialization Officer
  • --
  • Dr. Robert M. Plenge
  • Executive Vice President, Chief Research Officer and Head of Research
  • --
  • Gregory Scott Meyers
  • Executive Vice President, Chief Digital Officer and Chief Technology Officer
  • --
  • Karin Shanahan
  • Executive Vice President, Global Product Development and Supply
  • --
  • Cari Gallman
  • Executive Vice President, Corporate Affairs
  • --
  • Sandra Leung
  • Executive Vice President and General Counsel
  • 5.92M
  • Phil Holzer
  • Senior Vice President and Controller
  • --
  • Lynelle Hoch
  • President, Cell Therapy Organization
  • --
  • Dr. Manuel Hidalgo Medina, M.D.,PhD
  • Independent Director
  • 335.00K
  • Michael R. McMullen
  • Independent Director
  • --
  • Phyllis R. Yale
  • Independent Director
  • 365.00K
  • Dr. Deepak L. Bhatt, M.D.,M.P.H.
  • Independent Director
  • 329.97K
  • Paula A. Price
  • Independent Director
  • 365.00K
  • Dr. Karen H. Vousden, PhD
  • Independent Director
  • 344.74K
  • Peter J. Arduini
  • Independent Director
  • 359.68K
  • Dr. Julia A. Haller, M.D.
  • Independent Director
  • 371.68K
  • Theodore R. Samuels
  • Lead Independent Director
  • 425.00K
  • Derica W. Rice
  • Independent Director
  • 375.00K
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Cancer Research
Cancer Research
Intraday+0.11%